Skip to main content
. 2014 Nov 4;119(4):350–353. doi: 10.3109/03009734.2014.955619

Table III.

Dosing of intravenous iron and erythropoiesis-stimulating agent during iron supplementation and during combination treatment (erythropoiesis-stimulating agent plus intravenous iron). Data are expressed as mean ± SD.

Parameter Prior to combination treatment During combination treatment
Dose of i.v. iron (mg/week) 125 ± 40 126 ± 68
Dose of ESA (U/week) 0 17,300 ± 15,300
Number of RBC units transfused (units/month) 0.23 ± 0.28 0.44 ± 0.56

ESA = erythropoiesis-stimulating agent; RBC = red blood cell; U = unit.